Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial.
Viale G, de Snoo FA, Slaets L, Bogaerts J, van 't Veer L, Rutgers EJ, Piccart-Gebhart MJ, Stork-Sloots L, Glas A, Russo L, Dell'Orto P, Tryfonidis K, Litière S, Cardoso F; MINDACT investigators. Viale G, et al. Among authors: de snoo fa. Breast Cancer Res Treat. 2018 Jan;167(1):123-131. doi: 10.1007/s10549-017-4509-9. Epub 2017 Sep 19. Breast Cancer Res Treat. 2018. PMID: 28929359 Clinical Trial.
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial.
Viale G, Slaets L, Bogaerts J, Rutgers E, Van't Veer L, Piccart-Gebhart MJ, de Snoo FA, Stork-Sloots L, Russo L, Dell'Orto P, van den Akker J, Glas A, Cardoso F; TRANSBIG Consortium & the MINDACT Investigators. Viale G, et al. Among authors: de snoo fa. Ann Oncol. 2014 Apr;25(4):816-823. doi: 10.1093/annonc/mdu026. Ann Oncol. 2014. PMID: 24667714 Free PMC article. Clinical Trial.
Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis.
Drukker CA, Elias SG, Nijenhuis MV, Wesseling J, Bartelink H, Elkhuizen P, Fowble B, Whitworth PW, Patel RR, de Snoo FA, van 't Veer LJ, Beitsch PD, Rutgers EJ. Drukker CA, et al. Among authors: de snoo fa. Breast Cancer Res Treat. 2014 Dec;148(3):599-613. doi: 10.1007/s10549-014-3188-z. Epub 2014 Nov 21. Breast Cancer Res Treat. 2014. PMID: 25414025 Clinical Trial.
Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance.
Viale G, Slaets L, de Snoo FA, Bogaerts J, Russo L, van't Veer L, Rutgers EJ, Piccart-Gebhart MJ, Stork-Sloots L, Dell'Orto P, Glas AM, Cardoso F. Viale G, et al. Among authors: de snoo fa. Breast Cancer Res Treat. 2016 Feb;155(3):463-9. doi: 10.1007/s10549-016-3690-6. Epub 2016 Jan 28. Breast Cancer Res Treat. 2016. PMID: 26820652 Free PMC article. Clinical Trial.
European inter-institutional impact study of MammaPrint.
Cusumano PG, Generali D, Ciruelos E, Manso L, Ghanem I, Lifrange E, Jerusalem G, Klaase J, de Snoo F, Stork-Sloots L, Dekker-Vroling L, Lutke Holzik M. Cusumano PG, et al. Breast. 2014 Aug;23(4):423-8. doi: 10.1016/j.breast.2014.02.011. Epub 2014 Mar 28. Breast. 2014. PMID: 24685596 Free article.
Gene expression profiling: decoding breast cancer.
de Snoo F, Bender R, Glas A, Rutgers E. de Snoo F, et al. Surg Oncol. 2009 Dec;18(4):366-78. doi: 10.1016/j.suronc.2009.07.005. Surg Oncol. 2009. PMID: 19879448 Review.
41 results